share_log

HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target

Benzinga ·  May 14 23:19

HC Wainwright & Co. analyst Edward White reiterates Dynavax Technologies (NASDAQ:DVAX) with a Buy and maintains $29 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment